Early Stage

Solving the biggest problems in spinal deformity surgeries

Solving the biggest problems in spinal deformity surgeries


Funding data not publicly available

Dealmaker Securities

Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common


Series A

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity



San Diego, California

Business Type


Teslake is raising funds on Dealmaker. The company is solving the biggest problems in spinal deformity surgeries with robotics and a proprietary microbe-eradicating metal alloy. Their system combines state-of-the-art implants, their proprietary Guardinium™ Alloy, and a synchronized team of mini robots to make spinal deformity surgeries more predictable and easier. Thousands of implants are already in use, and with seven FDA-approved products and three patents filed, they are revenue positive. Stephen Foti, CEO, and Lukas Eisermann, President incorporated the business in 2019. The current crowdfunding campaign has a minimum target of $1,009 and a maximum target of $1.23 million. The campaign proceeds will be used for spine implants/instrument inventory, Guardinium Alloy instruments, SMR second generation, working capital, accounting, marketing & advertising, and intermediary fees.

Summary Profit and Loss Statement

FY 2022 FY 2021












Net Income



Summary Balance Sheet

FY 2022 FY 2021




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 08/29/2023
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Teslake on Dealmaker Securities 2023
Platform: Dealmaker Securities
Security Type: Equity - Common
Valuation: $30,910,768
Price per Share: $50.45

Follow company

Follow Teslake on Dealmaker Securities 2023

Buy Teslake's Deal Report

Teslake Deal Report

Get KingsCrowd’s comprehensive report on Teslake including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Teslake is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Teslake deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge